Forty-five women with fibromyalgia (FM) engaged in a 30-day electronic diary assessment, recording daily ratings of pain and 2 forms of maladaptive coping: pain catastrophizing and pain attention. Participants were genotyped for the val 158 met single nucleotide polymorphism (rs4680) in the catechol-O-methyltransferase (COMT) gene. COMT genotype moderated the daily relations of both maladaptive coping processes and pain. FM women with the homozygous met/met genotype evidenced more pain on days when pain catastrophizing was elevated relative to heterozygous and homozygous val 158 carriers. FM women with the homozygous met/met genotype evidenced more pain on days when pain attention was elevated relative to those with the homozygous val/val genotype. Evidence is presented to suggest that these are independent effects. The findings provide multimeasure and multimethod support for genetic moderation of a maladaptive coping and pain process, which has been previously characterized in a sample of postoperative shoulder pain patients. Further, the findings advance our understanding of the role of COMT in FM, suggesting that genetic variation in the val 158 met polymorphism may affect FM pain through pathways of pain-related cognition.
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Introduction
Chronic pain presents homeostatic challenges to an individual's affective regulatory system [46, 13] and psychiatric health [26, 28] . Patients use a variety of strategies to cope with chronic pain, and although many have been shown to reduce pain, some coping processes are maladaptive. Maladaptive coping processes, such as attention to pain and pain catastrophizing, promote heightened pain and functional disability in a variety of chronic pain groups [20, 30] . The harmful effects of maladaptive coping may be especially potent for patients with fibromyalgia (FM), a chronic pain disorder characterized by widespread musculoskeletal pain, as well as a reduced capacity for emotional resilience in the face of elevated pain [46] . Past research, however, has suggested that there is meaningful interindividual and intraindividual variability in FM patients' psychosocial response to pain [47] , as well as in pain reports themselves. A growing body of research has turned to genetics to help explain some of the variance in FM pain and its psychosocial concomitants [38, 21, 24, 13] . The purpose of the present investigation was to determine whether genetic variation in the catechol-O-methyltransferase (COMT) gene moderated the relations between maladaptive coping and pain in a sample of FM patients.
The COMT gene is thought to be involved in central pain processing via its direct regulation of dopaminergic pathways, which result in compensatory changes in opioidergic processing in response to pain [48, 8, 43] . The val 158 met single nucleotide polymorphism (SNP) (rs4680) has been the most commonly analyzed variant in COMT in the context of pain research. However, its role in FM is as yet unclear, as no large-scale association study (e.g., N > 1000) has been reported, and its association with complex process-oriented phenotypes in chronic pain populations is only beginning to be elucidated [13] . COMT's role in the relation of maladaptive coping for chronic pain was examined by George et al.
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